Company: LICN
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001213900-25-036244
Chunk: 98

Company: Lichen International Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 98
---
 Limited                                              
  By:                               /s/ Ya Li                               
                                    Name:          Ya Li                    
                                    Title:         Chief Executive Officer  

Date: April
28, 2025

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

LICHEN INTERNATIONAL LIMITED AND SUBSIDIARIES

For The Year Ended December 31, 2024

TABLE OF CONTENTS

  Content                                                                                                                         Page(s)  
  Report of Independent Registered Public Accounting Firm PCAOB ID # 6907                                                         F-2      
  Report of Independent Registered Public Accounting Firm PCAOB ID #6706                                                          F-3      
  Consolidated Balance Sheets as of December 31, 2024 and 2023                                                                    F-4      
  Consolidated Statements of Operations and Comprehensive (Loss) Income for the years ended December 31, 2024, 2023 and 2022      F-5      
  Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2024, 2023 and 2022                 F-6      
  Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022                                      F-7      
  Notes to Consolidated Financial Statements                                                                                      F-8      

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM

To the Board of Directors and

Shareholders of Lichen International Limited (formerly known as “ Lichen
China Limited)

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Lichen
International Limited and its subsidiaries(the “ Company”), a s
of December 31, 2024 and 2023, and the related consolidated statements of operations and comprehensive (loss) income, changes in shareholders’
equity and cash flows for each of the years ended December 31, 2024 and 2023, including the related notes (collectively referred to as
the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in
all material respects, the consolidated financial position of the Company as of December 31, 2024 and 2023, and the consolidated results
of its operations and its cash flo ws for the years ended December 31, 2024 and 2023,
in conformity with accounting principles generally accepted in the United States of America (“ U. S. GAAP”).

Basis for Opinion

These consolidated financial statements are